Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry

被引:14
|
作者
Ritchie, Andrew I. [1 ,2 ]
Donaldson, Gavin C. [1 ]
Hoffman, Eric A. [3 ,4 ]
Allinson, James P. [1 ,5 ]
Bloom, Chloe I. [1 ]
Bolton, Charlotte E. [6 ,7 ,8 ]
Choudhury, Gourab [9 ]
Gerard, Sarah E. [4 ]
Guo, Junfeng
Alves-Moreira, Luana [1 ]
McGarvey, Lorcan [10 ,11 ]
Sapey, Elizabeth [12 ]
Stockley, Robert A. [12 ]
Yip, K. P. [12 ]
Singh, Dave [13 ]
Wilkinson, Tom [14 ,15 ]
Fageras, Malin [16 ]
Ostridge, Kristoffer [14 ,16 ]
Joens, Olaf [17 ]
Bucchioni, Enrica [18 ]
Compton, Chris H. [19 ]
Jones, Paul [19 ]
Mezzi, Karen [20 ]
Vestbo, Jorgen [13 ]
Calverley, Peter M. A. [21 ]
Wedzicha, Jadwiga A. [1 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] AstraZeneca, Cambridge, England
[3] Univ Iowa, Dept Radiol, Iowa City, IA USA
[4] Univ Iowa, Roy J Carver Dept Biomed Engn Med & Biomed Engn, Iowa City, IA USA
[5] Royal Brompton Hosp, London, England
[6] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England
[7] Univ Nottingham, Ctr Resp Res, NIHR Nottingham, Translat Med Sci,Sch Med, Nottingham, England
[8] Queens Med Res Inst, ELEGI Labs, Edinburgh, Midlothian, Scotland
[9] Queens Med Res Inst, COLT Labs, Edinburgh, Midlothian, Scotland
[10] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[11] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[12] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England
[13] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England
[14] Univ Southampton, Fac Med, Southampton, Hants, England
[15] Southampton Univ Hosp, Natl Inst Hlth & Care Res, Southampton Biomed Res Ctr, Southampton, Hants, England
[16] AstraZeneca, Gothenburg, Sweden
[17] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[18] Chiesi Farmaceut SpA, Parma, Italy
[19] GlaxoSmithKline, Brentford, England
[20] Novartis Pharma AG, Basel, Switzerland
[21] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England
基金
美国国家卫生研究院;
关键词
chronic obstructive pulmonary disease; early COPD; FEV1; lung function; quantitative computed tomography; AIR-FLOW OBSTRUCTION; CHRONIC MUCUS HYPERSECRETION; COMPUTED-TOMOGRAPHY; NATURAL-HISTORY; DISEASE; EMPHYSEMA; STANDARDIZATION; ASSOCIATION; PHENOTYPE; UPDATE;
D O I
10.1164/rccm.202307-1203OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. Objectives: We hypothesized that structural change would be detected early in the natural history of COPD and would relate to loss of lung function with time. Methods: We recruited 431 current smokers (median age, 39 yr; 16 pack-years smoked) and recorded symptoms using the COPD Assessment Test (CAT), spirometry, and quantitative thoracic computed tomography (QCT) scans at study entry. These scan results were compared with those from 67 never-smoking control subjects. Three hundred sixty-eight participants were followed every six months with measurement of postbronchodilator spirometry for a median of 32months. The rate of FEV1 decline, adjusted for current smoking status, age, and sex, was related to the initial QCT appearances and symptoms, measured using the CAT. Measurements and Main Results: There were no material differences in demography or subjective CT appearances between the young smokers and control subjects, but 55.7% of the former had CAT scores greater than 10, and 24.2% reported chronic bronchitis. QCT assessments of disease probability-defined functional small airway disease, ground-glass opacification, bronchovascular prominence, and ratio of small blood vessel volume to total pulmonary vessel volume were increased compared with control subjects and were all associated with a faster FEV1 decline, as was a higher CAT score. Conclusions: Radiological abnormalities on CT are already established in young smokers with normal lung function and are associated with FEV1 loss independently of the impact of symptoms. Structural abnormalities are present early in the natural history of COPD and are markers of disease progression.
引用
收藏
页码:1208 / 1218
页数:11
相关论文
共 50 条
  • [41] Heme oxygenase 1 variations and lung function decline in smokers:: proof of replication
    Siedlinski, M.
    van Diemen, C. C.
    Postma, D. S.
    Boezen, H. M.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (06) : 400 - 400
  • [42] Indoor Pollution and Lung Function Decline in Current and Former Smokers SPIROMICS AIR
    Hansel, Nadia N.
    Woo, Han
    Koehler, Kirsten
    Gassett, Amanda
    Paulin, Laura M.
    Alexis, Neil E.
    Putcha, Nirupama
    Lorizio, Wendy
    Fawzy, Ashraf
    Belz, Daniel
    Sack, Coralynn
    Barr, R. Graham
    Martinez, Fernando J.
    Han, MeiLan K.
    Woodruff, Prescott
    Pirozzi, Cheryl
    Paine, Robert, III
    Barjaktarevic, Igor
    Cooper, Christopher B.
    Ortega, Victor
    Zusman, Marina
    Kaufman, Joel D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (10) : 1042 - 1051
  • [43] Around 20% Of Heavy Smokers Show A Rapid Annual Decline In Lung Function
    Bruijnzeel, P.
    Taib, Z.
    Dahlback, M.
    Van Geest, M.
    Sarv, J.
    Mo, J.
    Ostling, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] THE PREVALENCE OF REDUCED TLCO AND THE EMPHYSEMA INDEX IN SMOKERS WITH NORMAL SPIROMETRY
    Cheung, Timothy
    Papanikolaou, Vicki
    Finlay, Paul
    Lau, Ken
    Yong, Theresa
    Macdonald, Martin
    Bardin, Philip
    King, Paul
    RESPIROLOGY, 2017, 22 : 78 - 78
  • [45] Plasma pro-surfactant protein B and lung function decline in smokers
    Leung, Janice M.
    Mayo, John
    Tan, Wan
    Tammemagi, C. Martin
    Liu, Geoffrey
    Peacock, Stuart
    Shepherd, Frances A.
    Goffin, John
    Goss, Glenwood
    Nicholas, Garth
    Tremblay, Alain
    Johnston, Michael
    Martel, Simon
    Laberge, Francis
    Bhatia, Rick
    Roberts, Heidi
    Burrowes, Paul
    Manos, Daria
    Stewart, Lori
    Gingras, Michel
    Pasian, Sergio
    Tsao, Ming-Sound
    Lam, Stephen
    Sin, Don D.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (04) : 1037 - 1045
  • [46] Emphysema at CT in Smokers with Normal Spirometry: Why It Is Clinically Significant
    Grenier, Philippe A.
    RADIOLOGY, 2020, 296 (03) : 650 - 651
  • [47] Reduced ventilatory efficiency and muscle endurance in smokers with normal spirometry
    Faisal, Azmy
    Sadaka, Ahmad S.
    Purcell, Helen
    Polkey, Michael I.
    Hopkinson, Nicholas S.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [48] Analysis of Smokers With Normal Spirometry on the athletic performance of Athletes.
    Tan, Min
    Song, Xiaolian
    Xiao, Yi
    Li, Xuan
    Xie, Shuanshuan
    Li, Qingchu
    Li, Guoshu
    Liu, Yang
    Wang, Liping
    Wang, Changhui
    REVISTA INTERNACIONAL DE MEDICINA Y CIENCIAS DE LA ACTIVIDAD FISICA Y DEL DEPORTE, 2022, 22 (88): : 292 - 309
  • [49] Differences in regional air trapping in current smokers with normal spirometry
    Karimi, Reza
    Tornling, Goran
    Forsslund, Helena
    Mikko, Mikael
    Wheelock, Asa M.
    Nyren, Sven
    Skold, C. Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (01)
  • [50] Spirometry guidelines influence lung function results in a longitudinal study of young adults
    Smith, Lewis J.
    Arynchyn, Alexander
    Kalhan, Ravi
    Williams, O. Dale
    Jensen, Robert
    Crapo, Robert
    Jacobs, David R., Jr.
    RESPIRATORY MEDICINE, 2010, 104 (06) : 858 - 864